IIMA Ventures-Backed Curelo Raises INR 10 Cr Funding from Shreyas Iyer and Industry Experts
Share
Curelo, the innovative health-tech platform founded by Laparoscopic Surgeon Dr. Arpit Jayswal, has secured a significant boost with a strategic investment from ace Indian cricketer, Shreyas Iyer. The entire round consists of INR 10 Cr where apart from Shreyas Iyer, the team got investments from IIMA Ventures, renowned industry experts like Tarun Katial (Founder of Zee 5) and family offices in US.
Shreyas Iyer, who is known for his dynamic performances and commitment on the field, has extended his support to Curelo, bringing not just financial support but a belief in its vision. “I’m pleased to be a part of Curelo’s journey. I firmly believe that health and fitness should constitute a key part in everyone’s daily routine which resonates with Curelo’s commitment to provide accessible and efficient services. They have an innovative and customer-friendly approach to diagnostics and healthcare, and I am excited to contribute to its growth,” shared Shreyas Iyer, who is exclusively managed by RISE Worldwide.
Curelo, founded in 2022 by Dr. Arpit Jayswal, has rapidly emerged as a disruptive force in the healthcare sector. The aggregator platform connects patients with diagnostic labs, offering at-home blood sample collection and timely reports. With a fleet of phlebotomists ensuring samples are collected within 60 minutes of booking, Curelo’s revenue has grown 25 times over the last year.
Dr. Arpit Jayswal, Curelo’s Founder and CEO, expressed his excitement about having Shreyas Iyer on board as an investor. He highlighted the company’s commitment to optimizing user experience, standardising sample collection, and scaling operations nationwide. “We are delighted to welcome Shreyas Iyer as an investor in Curelo. His belief in our platform adds immense value as we continue to redefine the diagnostic market. This collaboration positions us as a trusted brand with accelerated growth and reinforces our commitment to serving the evolving needs of our users,” said Dr. Jayswal
The recent round of investment from IIMA Ventures, Shreyas Iyer and industry experts marks a significant milestone for Curelo, positioning the platform to continue its growth trajectory in the highly competitive Indian healthcare market. The funds will be instrumental in further expanding Curelo’s footprint, standardizing unorganized labs, and achieving exponential growth in acquiring 300% more patients in the coming year.
